
02.03.2020
Acino completes acquisition with Takeda for primary care portfolio in key emerging markets
Acino and Takeda Pharmaceuticals announced today the completion of the acquisition for parts of Takeda’s primary care portfolio in selected...
Acino and Takeda Pharmaceuticals announced today the completion of the acquisition for parts of Takeda’s primary care portfolio in selected...
Acino is proud to have been recognised as the Best Pharmaceutical Company 2019 by the Armenia Diaspora association in Armenia...
Acino’s manufacturing plant in Ukraine—Pharma Start—has successfully been certified according to the Good Manufacturing Practice of the European Union (EU...
On December 18, Acino completed the registration of the company as a legal entity in Turkey, paving the way to...
Under the headline ‘Acino and Quay steer new course for contract development and manufacturing.’ our Contract Manufacturing team recently spoke to...
Acino Contract Manufacturing is pleased to announce a strategic partnership with UK-based Quay Pharma for the formulation and development of...
Acino and Takeda Pharmaceuticals announced today that they have signed an agreement for Acino to acquire parts of Takeda’s primary...
We are pleased to announce the appointment of Ralph Halter as the new Global Head of IT and a member...
We are pleased to announce the appointment of Steve Mahoney as Head of Region – English-Speaking Africa, Latin America and...